We are live on ! Find out more
CO

Global Cord Blood Corporation

Delisted

CO was delisted on the 23rd of September, 2022.

33 hedge funds and large institutions have $22M invested in Global Cord Blood Corporation in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 12 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

6% less funds holding

Funds holding: 3533 (-2)

33% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 12

77% less capital invested

Capital invested by funds: $96.3M → $22M (-$74.3M)

100% less funds holding in top 10

Funds holding in top 10: 20 (-2)

Holders
33
Holders Change
-2
Holders Change %
-5.71%
% of All Funds
0.73%
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
4
Increased
8
Reduced
12
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Simplex Trading
26
Simplex Trading
Illinois
$10K +$4.26K +974 +45%
UBS Group
27
UBS Group
Switzerland
$7K -$245 -56 -3%
Group One Trading
28
Group One Trading
Illinois
$6K
TRCT
29
Tower Research Capital (TRC)
New York
$4K +$590 +135 +12%
Royal Bank of Canada
30
Royal Bank of Canada
Ontario, Canada
$1K +$188 +43 +15%
AC
31
Athos Capital
Hong Kong
-$299K -59,862 Closed
GCP
32
GSA Capital Partners
United Kingdom
-$132K -26,400 Closed
Deutsche Bank
33
Deutsche Bank
Germany
-$22K -4,501 Closed
Wells Fargo
34
Wells Fargo
California
-$4 -1 -5%
Osaic Holdings
35
Osaic Holdings
Arizona
+$568 +130 New

CO Hedge Fund Activity: Q1 2020 in Review

33 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q1 2020, worth a combined $22M — down 77% from $96.3M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new CO positions and 3 closed out — a net gain of 1 holder — while 8 added to existing stakes and 12 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $550K. The largest seller was Man Group, cutting an estimated $1.18M.

  • 33 institutional investors held Global Cord Blood Corporation (CO) as of Q1 2020, down from 35 in Q4 2019.
  • Funds reported $22M of Global Cord Blood Corporation stock for Q1 2020, down 77% quarter-over-quarter.
  • 4 funds opened new Global Cord Blood Corporation positions in Q1 2020 and 3 closed out, a net change of +1 holder.
  • The largest Global Cord Blood Corporation buyer in Q1 2020 was Renaissance Technologies, an estimated $550K added.
  • The largest Global Cord Blood Corporation seller in Q1 2020 was Man Group, an estimated $1.18M sold.

Based on aggregated 13F filings for Q1 2020.